Tag: Biotech
DLA Piper adds two partners and a team from Sidley and Weil
DLA Piper has strengthened its capital markets capabilities in Hong Kong and Chinese mainland with two major hires
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
Opportunities in Japan’s regenerative medicine, gene therapy markets
Japan emerges as a hub for regenerative medicine, with opportunities for foreign companies amid strict local regulations
Out-licensing is in
China's out-licensing boom: legal experts share tips for seamless pharma deals
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
IP flip
GC and senior lawyers decode China's new IP trends
